Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivo.
HSV-1716 is a replication-restricted, neuroattenuated ICP 34.5 gene mutant of herpes simplex virus type 1 (HSV-1). Because of the attenuated phenotype of ICP 34.5 mutants in rodent models of HSV disease, they have been promoted as potential vaccine strains and gene therapy vectors and have been used by us and others as therapeutic agents for the treatment of experimental malignant tumors. However, all data on the phenotype of HSV-1716 and other ICP 34.5 mutants are from animal model systems, while humans are the natural hosts of HSV-1. To achieve an initial characterization of the phenotype of 1716 in human tissue, we have studied its replication in mature human skin xenografts on SCID mice. We find that replication of 1716 is severely restricted in such human skin grafts relative to both parental wild-type HSV-1 strain 17+ and the HSV-1716 revertant virus 1716R, in which the 759-bp ICP 34.5 gene deletions have been repaired. Moreover, the replication of both 1716 and 17+ is significantly better in the human skin grafts than it is in mouse skin. The implications of these findings are discussed.
Randazzo
B P
BP
Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Kucharczuk
J C
JC
Litzky
L A
LA
Kaiser
L R
LR
Brown
S M
SM
MacLean
A
A
Albelda
S M
SM
Fraser
N W
NW
D000818:Animals; D017353:Gene Deletion; D006801:Humans; D051379:Mice; D016513:Mice, SCID; D018139:Simplexvirus / Q000235:genetics* / Q000254:growth & development*; D016038:Skin Transplantation / Q000473:pathology; D014183:Transplantation, Heterologous; D014779:Virus Replication